Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury

Renal Failure

Volumn 35, Issue 2, 2013, Pages 291-294

  Koçkara, Ayşe ^a   Kayataş, Mansur ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Apoptosis; New treatment options; Renal failure; Sepsis

Indexed keywords

CASPASE 3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10;

ACUTE KIDNEY FAILURE; APOPTOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; KIDNEY BIOPSY; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK;

ACUTE KIDNEY INJURY; APOPTOSIS; CELLS, CULTURED; FEMALE; FORECASTING; HEMOFILTRATION; HUMANS; KIDNEY; MALE; RENAL INSUFFICIENCY; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84873641883     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.744040     Document Type: Review

References (32)

1. Henkart PA. Apoptosis: o death, where is thy sting? J Immunol. 1995;154(10):4905-4908.
2. Steller H. Mechanisms and genes of cellular suicide. Science. 1995;267(5203):1445-1449.
3. Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. J Am Med Assoc. 1998;279:300-307.
4. Alnemri ES, Livingston DJ, Nicholson DW, et al. ICE/CED-3 protease nomenclature. Cell. 1996;87(2):171.
5. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 1999;68:383-424.
6. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281(5381):1312-1316.
7. Hengardner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776.
8. Ortiz A, Cuadrado SG, Lorz C, Egido J. Apoptosis in renal diseases. Front Biosci. 1996;1:30-47.
9. Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY. Inflammatory cytokines and lipopolysaccharide induce Fasmediated apoptosis in renal tubular cells. Nephron. 2002;91:406-415.
10. Messmer UK, Briner VA, Pfeilschifter J. Tumor necrosis factoralpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int. 1999;55:2322-2337.
11. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36(Suppl. 4):S198-S203.
12. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med. 1999;27:1230-1251.
13. Lerolle N, Nochy D, Guérot E. Histopathology of septic shock induced renal injury: apotosis and leukocytic infiltration. Intensive Care Med. 2010;36:471-478.
14. Jacobs R, Honore PM, Joannes-Boyau O, et al. Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis. Blood Purif. 2011;32:262-265.
15. Homsi E, Janino P, de Faria JB. Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int. 2006;69:1385-1392.
16. Lee SY, Lee YS, Choi HM, et al. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med. 2012;40(11): 2997-3006.
17. Bone RC. Sepsis, the sepsis syndrome, multiorgan failure: a plea for comparable definitions. Ann Intern Med. 1991;114:332.
18. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885-891.
19. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138-150.
20. Cantaluppi V, Assenzio B, Pasero D, et al. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008;34:1638-1645.
21. Wang W, Bansal S, Falk S, Ljubanovic D, Schrier RW. Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am J Physiol Renal Physiol. 2009;297:F1032-F1037.
22. Simon F, Giucidi R, Scheurle A. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care. 2009;13:R113.
23. Bahlmann FH, Fliser D. Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens. 2009;18:15-20.
24. Jungers P,ChoukrounG,OualimZ, RobinoC,NguyenAT,Man NK. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant. 2001;16:307-312.
25. Montori VM, Bistrian BR, McMahon MM. Hyperglycemia in acutely ill patients. J Am Med Assoc. 2002;288:2167-2169.
26. Vanhorebeek I, Van den Berghe G. Diabetes of injury: novel insights. Endocrinol Metab Clin North Am. 2006;35:859-872.
27. Langouche L, Vanhorebeek I, Vlasselaers D. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277-2286.
28. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
29. Van den Berghe G, Wilmer A, Hermans G. Intensive insulin therapy in the medical ICU. New Engl JMed. 2006;354:449-461.
30. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MM. High glucose-induced oxidative stres causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J. 2003;17:908-910.
31. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19(3):571-578.
32. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. J Am Med Assoc. 2003;289:2104-2112.